![David Gobel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Gobel
Direktor/Vorstandsmitglied bei
VIVOSIM LABS, INC.
Vermögen: 4 365 $ am 31.08.2026
Profil
Mr. David Gobel is an Independent Director at VivoSim Labs, Inc., a Chairman at Turn Biotechnologies, Inc., a Chief Executive Officer at Methuselah Capital Management LLC, a Chief Executive Officer at Methuselah Funds LLC, an Independent Director at Oisin Biotechnologies, Inc. and a Chief Executive Officer at Methuselah Foundation.
He is on the Board of Directors at VivoSim Labs, Inc., Leucadia Therapeutics, Inc. and Oisin Biotechnologies, Inc. Mr. Gobel was previously employed as a Chief Venture Strategist by Transportation Security Administration.
He also served on the board at Volumetric Biotechnologies, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VIVOSIM LABS INC 0.58% | 13.08.2026 | 15’000 ( 0.58% ) | 4 365 $ | 31.08.2026 |
Aktive Positionen von David Gobel
| Unternehmen | Position | Beginn |
|---|---|---|
| VIVOSIM LABS, INC. | Direktor/Vorstandsmitglied | 15.09.2020 |
Oisin Biotechnologies, Inc.
 Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Provides biological solutions to degenerative aging conditions | Direktor/Vorstandsmitglied | 01.12.2014 |
Methuselah Capital Management LLC
 Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management invests in companies located in the United States. The firm target companies operating across a broad range of sectors. It provides financing for early stage capital requirements. | Vorstandsvorsitzender | 01.01.2017 |
Leucadia Therapeutics, Inc.
 Leucadia Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops diagnostic algorithm for alzheimer disease prevention and treatment | Direktor/Vorstandsmitglied | 01.10.2015 |
Methuselah Foundation
 Methuselah Foundation Investment Trusts/Mutual FundsMiscellaneous Operates as a biomedical charity which focuses on human lifespan and improving longevity | Vorstandsvorsitzender | 01.09.2001 |
Turn Biotechnologies, Inc.
 Turn Biotechnologies, Inc. Packaged SoftwareTechnology Services Develops proprietary ERA platform that enables to discover pharmaceutical therapeutics | Vorsitzender | 01.05.2020 |
Methuselah Funds LLC
 Methuselah Funds LLC Investment ManagersFinance Acts as Venture Capital Fund | Vorstandsvorsitzender | 01.12.2016 |
Ehemalige bekannte Positionen von David Gobel
| Unternehmen | Position | Ende |
|---|---|---|
Volumetric Biotechnologies, Inc. | Direktor/Vorstandsmitglied | 01.01.2020 |
Transportation Security Administration
 Transportation Security Administration General GovernmentGovernment Operates and manages transportation security system | Corporate Officer/Principal | 01.03.2013 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
41
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
VivoSim Labs, Inc.
 VivoSim Labs, Inc. BiotechnologyHealth Technology Engages in developing and commercializing functional human tissues | Health Technology |
Transportation Security Administration
Transportation Security Administration General GovernmentGovernment Operates and manages transportation security system | Government |
Methuselah Foundation
Methuselah Foundation Investment Trusts/Mutual FundsMiscellaneous Operates as a biomedical charity which focuses on human lifespan and improving longevity | Miscellaneous |
Oisin Biotechnologies, Inc.
Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Provides biological solutions to degenerative aging conditions | Health Technology |
Methuselah Funds LLC
Methuselah Funds LLC Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Methuselah Capital Management LLC
Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management invests in companies located in the United States. The firm target companies operating across a broad range of sectors. It provides financing for early stage capital requirements. | Finance |
Leucadia Therapeutics, Inc.
Leucadia Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops diagnostic algorithm for alzheimer disease prevention and treatment | Health Technology |
Turn Biotechnologies, Inc.
Turn Biotechnologies, Inc. Packaged SoftwareTechnology Services Develops proprietary ERA platform that enables to discover pharmaceutical therapeutics | Technology Services |
Volumetric Biotechnologies, Inc. |
